Dr. Olugbile is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1800 Howell Mill Rd NW Ste 300
Atlanta, GA 30318Phone+1 404-425-1777Fax+1 860-456-6788
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2014 - 2017
Yale-New Haven Medical CenterResidency, Internal Medicine, 2011 - 2014
University of Lagos College of MedicineClass of 2001
Certifications & Licensure
GA State Medical License 2024 - 2026
CT State Medical License 2019 - 2025
OH State Medical License 2017 - 2021
IL State Medical License 2014 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 9 citationsSeroprevalence of SARS-CoV-2 antibodies, associated epidemiological factors and antibody kinetics among healthcare workers in Connecticut.Pavlos K. Papasavas, Sope Olugbile, Ulysses Wu, Kenneth J. Robinson, Amity L. Roberts
The Journal of Hospital Infection. 2021-04-27 - 1 citationsFactors affecting seroreversion by 6 months among healthcare workers in Connecticut.A Althoff, P Papasavas, S Olugbile, U Wu, A L Roberts
The Journal of Hospital Infection. 2022-03-01 - 44 citationsEffective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer.Hiroyuki Inoue, Taigo Kato, Sope Olugbile, Kenji Tamura, Suyoun Chung
Oncotarget. 2016-02-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
